Mitochondrial DNA A3243G variant-associated MELAS: Recent advances in clinical trials, therapeutic interventions, and disease-modifying strategies.

Chu KY

Open source

DOI
10.5582/irdr.2026.01026
Published
2026 Aug 31
Container
Intractable & rare diseases research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5582/irdr.2026.01026,
  title = {Mitochondrial DNA A3243G variant-associated MELAS: Recent advances in clinical trials, therapeutic interventions, and disease-modifying strategies.},
  author = {Chu KY},
  year = {2026},
  journal = {Intractable \& rare diseases research},
  doi = {10.5582/irdr.2026.01026},
  url = {https://doi.org/10.5582/irdr.2026.01026}
}

RIS

TY  - JOUR
TI  - Mitochondrial DNA A3243G variant-associated MELAS: Recent advances in clinical trials, therapeutic interventions, and disease-modifying strategies.
AU  - Chu KY
PY  - 2026
JO  - Intractable & rare diseases research
DO  - 10.5582/irdr.2026.01026
UR  - https://doi.org/10.5582/irdr.2026.01026
ER  - 

APA

KY, C. (2026). Mitochondrial DNA A3243G variant-associated MELAS: Recent advances in clinical trials, therapeutic interventions, and disease-modifying strategies.. Intractable & rare diseases research. https://doi.org/10.5582/irdr.2026.01026

Source records